Carisma Therapeutics Statistics
Total Valuation
CARM has a market cap or net worth of $45.70 million. The enterprise value is -$3.33 million.
| Market Cap | 45.70M |
| Enterprise Value | -3.33M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CARM has 41.54 million shares outstanding. The number of shares has increased by 220.24% in one year.
| Shares Outstanding | 41.54M |
| Shares Change (YoY) | +220.24% |
| Shares Change (QoQ) | +22.12% |
| Owned by Insiders (%) | 28.68% |
| Owned by Institutions (%) | 39.63% |
| Float | 22.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.03 |
| Forward PS | 2.69 |
| PB Ratio | 4.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.64, with a Debt / Equity ratio of 0.69.
| Current Ratio | 4.64 |
| Quick Ratio | n/a |
| Debt / Equity | 0.69 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 21.61 |
Financial Efficiency
Return on equity (ROE) is -216.00% and return on invested capital (ROIC) is -463.75%.
| Return on Equity (ROE) | -216.00% |
| Return on Assets (ROA) | -80.60% |
| Return on Capital (ROIC) | -463.75% |
| Revenue Per Employee | $140,869 |
| Profits Per Employee | -$759,019 |
| Employee Count | 107 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -109,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.99% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -87.99% |
| 50-Day Moving Average | 1.27 |
| 200-Day Moving Average | 2.21 |
| Relative Strength Index (RSI) | 42.24 |
| Average Volume (20 Days) | 2,127,650 |
Short Selling Information
The latest short interest is 1.95 million, so 4.70% of the outstanding shares have been sold short.
| Short Interest | 1.95M |
| Short Previous Month | 1.37M |
| Short % of Shares Out | 4.70% |
| Short % of Float | 8.68% |
| Short Ratio (days to cover) | 8.30 |
Income Statement
In the last 12 months, CARM had revenue of $15.07 million and -$81.22 million in losses. Loss per share was -$1.96.
| Revenue | 15.07M |
| Gross Profit | 15.07M |
| Operating Income | -85.27M |
| Pretax Income | -81.32M |
| Net Income | -81.22M |
| EBITDA | -75.99M |
| EBIT | -85.27M |
| Loss Per Share | -$1.96 |
Balance Sheet
The company has $56.52 million in cash and $7.49 million in debt, giving a net cash position of $49.02 million or $1.18 per share.
| Cash & Cash Equivalents | 56.52M |
| Total Debt | 7.49M |
| Net Cash | 49.02M |
| Net Cash Per Share | $1.18 |
| Equity (Book Value) | 10.90M |
| Book Value Per Share | 0.26 |
| Working Capital | 47.81M |
Cash Flow
In the last 12 months, operating cash flow was -$78.07 million and capital expenditures -$1.01 million, giving a free cash flow of -$79.08 million.
| Operating Cash Flow | -78.07M |
| Capital Expenditures | -1.01M |
| Free Cash Flow | -79.08M |
| FCF Per Share | -$1.93 |
Margins
Gross margin is 100.00%, with operating and profit margins of -565.71% and -538.81%.
| Gross Margin | 100.00% |
| Operating Margin | -565.71% |
| Pretax Margin | -539.53% |
| Profit Margin | -538.81% |
| EBITDA Margin | -504.11% |
| EBIT Margin | -565.71% |
| FCF Margin | -524.66% |
Dividends & Yields
CARM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -220.24% |
| Shareholder Yield | -220.24% |
| Earnings Yield | -177.73% |
| FCF Yield | -173.06% |
Analyst Forecast
The average price target for CARM is $8.00, which is 627.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 627.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | -3.56% |
| EPS Growth Forecast (5Y) | -5.54% |
Stock Splits
The last stock split was on March 8, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Mar 8, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
CARM has an Altman Z-Score of -7.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.41 |
| Piotroski F-Score | 2 |